Triple-negative breast cancer: role of specific chemotherapy agents.Isakoff SJ. Cancer J. 2010 Jan-Feb;16(1):53-61. Review.
Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Isakoff SJ, Engelman JA, Irie HY, Luo J, Brachmann SM, Pearline RV, Cantley LC, Brugge JS. Cancer Res. 2005 Dec 1;65(23):10992-1000.
As part of the multidisciplinary approach to breast cancer treatment, Mass General Cancer Center patients receive care from an integrated team of pathologists, radiologists, and medical, surgical, and radiation oncologists.